A research study looking at how the compound NNC0194-0499 works with birth control pills in women not able to bear children.

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- First administration to humans

Sponsor

Novo Nordisk A/S

Enrolment target

30

Start

17 Jul 2023

Age 18 Years to any · Sex: Female

• —

  Austria